Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients

被引：4
|
作者：
Alavian, SM
Hajarizadeh, B
Einollahi, B
机构：
[1] Baghiatollah Univ Med Sci, Dept Gastroenterol, Tehran, Iran
[2] Baghiatollah Univ Med Sci, Dept Nephrol, Tehran, Iran
来源：
TRANSPLANTATION PROCEEDINGS | 2003年 / 35卷 / 07期
关键词：
D O I：
10.1016/j.transproceed.2003.08.042
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2687 / 2688
页数：2
相关论文
共 50 条
  • [21] THE EFFICACY OF LAMIVUDINE TREATMENT IN NAIVE CHRONIC HEPATITIS B PATIENTS
    Balkan, Ayhan
    Barutcu, Sezgin
    Erdem, Ramazan
    Konduk, Bugra Tolga
    Yildirim, Abdullah Emre
    Gulsen, Murat Taner
    ACTA MEDICA MEDITERRANEA, 2016, 32 (03): : 663 - 667
  • [22] The Efficacy of Lamivudine in the Treatment of Chronic Hepatitis B in Southeast of Iran
    Sanei-Moghaddam, Smail
    Salehi, Masoud
    Sharifi-Mood, Batool
    Zahedan, Sohila Kharkov
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S90 - S90
  • [23] Efficacy and safety in chronic hepatitis B adolescent patients with lamivudine therapy
    陆玮伦
    谢冬英
    姚集鲁
    姚光弼
    崔振宇
    张定凤
    吴磊
    中华肝脏病杂志, 2004, (07) : 50 - 52
  • [24] Efficacy and safety of adefovir dipivoxil treatment in patient with compensated chronic hepatitis B and decompensated chronic hepatitis B after lamivudine breakthrough
    Lee, Heon-Ju
    Eun, Jong-Ryul
    Choi, Sun-Taek
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A14 - A14
  • [25] Efficacy and safety of Adefovir for the treatment of patients with chronic hepatitis B (CHB) resistant to lamivudine in Spain
    Buti, M
    Esteban, R
    Escartin, P
    Calleja, JL
    Enriquez, J
    Pons, F
    Crespo, J
    Bengoechea, MG
    Prieto, M
    Casanovas, T
    Samaniego, JG
    Miras, M
    Roldan, FP
    Pelaez, M
    Fraga, E
    Moreira, V
    Carro, PG
    Rueda, M
    JOURNAL OF HEPATOLOGY, 2004, 40 : 125 - 125
  • [26] Efficacy and safety of Adefovir Dipivoxil treatment in patient with compensated chronic hepatitis B and decompensated chronic hepatitis B after Lamivudine breakthrough
    Choi, J. -W.
    Park, Y. -S.
    Kim, K. -H.
    Eun, J. -R.
    Lee, H. -J.
    LIVER INTERNATIONAL, 2006, 26 : 53 - 53
  • [27] Efficacy and safety of lamivudine (3TC) in renal transplant patients with chronic hepatitis B.
    Antoine, C
    Landau, A
    Menoyo, V
    Duong, JP
    Duboust, A
    Glotz, D
    TRANSPLANTATION, 1999, 67 (07) : S217 - S217
  • [28] Successful long-term use of lamivudine in kidney allograft recipients with chronic hepatitis B
    Watschinger, B
    Kletzmayr, J
    Demetriou, J
    Müller, D
    Kovarik, J
    TRANSPLANTATION, 1999, 67 (07) : S115 - S115
  • [29] OUTCOME OF RENAL TRANSPLANT RECIPIENTS WITH HEPATITIS B INFECTION AND PREEMPTIVE TREATMENT WITH LAMIVUDINE
    Bucsa, Cristina A.
    Tacu, Dorina B.
    Kerezsy, Eminee C.
    Manu, Marcian
    Hirza, Mihai
    Domnisor, Liliana
    Daia, Denise
    Serbanescu, Bogdan
    Stefan, Bogdan
    Burchiu, Eliza
    Sinescu, Ioanel
    TRANSPLANT INTERNATIONAL, 2009, 22 : 189 - 190
  • [30] Efficacy and safety of lamivudine in treatment of adolescent with HBeAg positive hepatitis B
    Yao, GB
    Huang, Y
    Ji, NX
    GASTROENTEROLOGY, 2003, 124 (04) : A763 - A763
12345